Search Results

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor

Orlando Health announces plans to build new freestanding emergency room in Lutz

The new freestanding emergency room will serve patients 24 hours a day, seven days a week and be fully staffed. The opening date for the new facility has not yet been announced.

Orlando Health Announces Plans to Build New Freestanding Emergency Room in Polk County

Orlando Health, headquartered in Orlando, Florida, is a private, not-for-profit healthcare organization with $9.6 billion of assets under management that serves the southeastern United States and Puerto Rico.

Orlando Health announces plans to build a freestanding emergency room in East Orange County

Orlando, FL (December 21, 2022) – Today, Orlando Health submitted to the Orange County Development Review Committee a request for a pre-application meeting along with renderings of a new freestanding emergency room (ER) the organization plans to build. The request provides specifications for the new ER, which features an 18,000 square foot facility with a capacity for up to 24 exam rooms, including two resuscitation rooms, a computerized tomography room, a radiology room, and a lab. It will be located at 11898 Lake Underhill Road, on a 5.57-acre site that was previously the location of a motorcycle dealership. 

Edward Hilt

A Study Testing the Combo of Dasatinib or Imatinib to Chemo Treatment W/ Blinatumomab for Children, Adolescents, & YA W/ Ph+ or Ph-Like B-cell B-ALL

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged ≥1 to <31 Years Old With First Relapse

Orlando Health Leads the Way in Protecting Prostate Cancer Patients from Radiation Side Effects

Orlando, FL (May 31, 2023) – Orlando Health Cancer Institute is leading the way in protecting prostate cancer patients from the harmful side effects of radiation therapy. The health system became the first in Central Florida to offer Barrigel, an advanced protective barrier that significantly reduces the exposure of the rectum to high doses of radiation during treatment.

Bayfront Health & Other Facilities in the Tampa Bay Region Align Under Orlando Health Name

St. Petersburg, FL (February 20, 2024) – Since October 2020, Pinellas County’s only Adult Trauma center has experienced significant enhancements and been a wonderful addition to the Orlando Health network of hospitals and medical facilities. In its continued commitment to Tampa Bay, Bayfront Health St. Petersburg is proud to add its parent company’s name and transition to Orlando Health Bayfront Hospital, starting March 1^st.